Cumberland Pharmaceuticals Inc
Research Cumberland Pharmaceuticals Inc (CPIX) on Bullrun: market cap USD 130.35M, dividend yield 17.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCPIX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 130.35M
- Dividend yield17.3%
- Financial periodQ2 2026
- RevenueUSD 8.80M
- Net income-USD 4.28M
- Free cash flow-USD 1.61M
Valuation Snapshot
latest market cap is USD 130.35M; dividend yield is 17.3%.
Peer valuation comparison
Latest dividend yield is 17.34% versus a Healthcare sector median of 2.11% (721.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 44.52M | -USD 2.84M | USD 4.83M | 85.0% | -0.19 | USD 11.44M | USD 0 | USD 24.88M |
| FY2024 | USD 37.87M | -USD 6.48M | -USD 678.65K | 82.6% | -0.46 | USD 17.96M | USD 5.10M | USD 22.85M |
| FY2023 | USD 39.55M | -USD 6.28M | USD 5.81M | 84.7% | -0.44 | USD 18.32M | USD 0 | USD 29.60M |
| FY2022 | USD 42.01M | -USD 5.57M | USD 8.35M | 78.3% | -0.38 | USD 19.76M | USD 19.51M | USD 36.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 130.35M | n/a | 17.2% | 1.5 |
| 2025 | 2025-12-31 | USD 59.53M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 33.07M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 26.68M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 32.54M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 68.85M | n/a | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.5 USD, yield 17.3%.
About Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cumberland Pharmaceuticals Inc's market cap?
Cumberland Pharmaceuticals Inc's market capitalization is USD 130.35M.
Does Cumberland Pharmaceuticals Inc pay a dividend?
Cumberland Pharmaceuticals Inc has a dividend yield of 17.3%.
What does Cumberland Pharmaceuticals Inc do?
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.